Hsp40 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Hsp40 (Heat Shock Protein 40, also known as DnaJ or DNAJB proteins) is a family of co-chaperones that work with Hsp70 to regulate protein folding, aggregation prevention, and protein quality control. The human genome contains over 40 Hsp40 family members.
| Protein Summary |
|---|
| Name | Hsp40 / DnaJ |
| Gene Family | DNAJ (multiple) |
| UniProt Range | Multiple (20-80 kDa) |
| Structure | J-domain, G/F-rich region |
| Localization | Cytoplasm, ER, mitochondria |
| Family | Hsp40 co-chaperone family |
Hsp40 proteins contain characteristic domains:
- J-domain: ~70 amino acids, mediates interaction with Hsp70
- G/F-rich region: Glycine-phenylalanine rich flexible linker
- C-terminal substrate-binding domain: Variable, determines specificity
- Stimulates Hsp70 ATPase activity
- Targets substrates to Hsp70
- Prevents protein aggregation
- ER-associated degradation (ERAD)
- Cytosolic protein folding
- Mitochondrial protein import
- Controls Hsp70 cycling
- Ensures proper substrate hand-off
- Modulates Hsp70 specificity
Hsp40 proteins are implicated in:
- Alzheimer's disease: DNAJC family members reduce Aβ aggregation
- Parkinson's disease: DNAJC proteins prevent alpha-synuclein aggregation
- ALS: Modulate mutant SOD1 and FUS aggregation
- Huntington's disease: DNAJC proteins assist mutant huntingtin clearance
Some Hsp40 members are overexpressed in cancers:
- DNAJA1, DNAJB1 have anti-apoptotic roles
- Potential therapeutic targets
| Name |
Gene |
Key Functions |
| Hsp40 |
DNAJB1 |
General protein folding |
| Hsp40-A1 |
DNAJA1 |
Cell cycle, apoptosis |
| Hsp40-B1 |
DNAJB1 |
ERAD, stress response |
| Cysteine string protein |
DNAJC5 |
Synaptic vesicle function |
- Hsp70-Hsp40 modulators: Under development for neurodegeneration
- Gene therapy: DNAJB family members being explored
- Small molecules: J-domain mimetics in research
- "Hsp40 co-chaperones in protein aggregation diseases" - Journal of Molecular Biology (2015) - PMID:25843232
- "DNAJB1 and alpha-synuclein aggregation" - Cell Reports (2018) - PMID:29320759
- "Hsp40 family in ER stress" - Cell Stress and Chaperones (2020) - PMID:31960421
- "Targeting Hsp40 in neurodegeneration" - Neurotherapeutics (2021) - PMID:33849376
Hsp40 proteins function as co-chaperones with Hsp70 family members:
- Hsp70 (HSPA1A): Primary partnering Hsp70 for protein folding
- Hsp90 (HSP90AA1): Client protein refolding and degradation
- CHIP (STUB1): E3 ubiquitin ligase for damaged protein clearance
- BAG family: Nucleotide exchange factors for Hsp70
- J-domain proteins: Other Hsp40 family members for substrate specificity
DnaJB1/Hsp40 alterations are implicated in:
- Neurodegenerative diseases: Protein aggregation in AD, PD, HD, ALS
- Cancer: Altered expression in various tumors
- Metabolic disorders: Insulin signaling and diabetes
- Aging: Declining chaperone capacity with age
Current research areas include:
- Developing Hsp40 modulators for therapeutic intervention
- Understanding J-domain specificity for drug design
- Gene therapy approaches for chaperone deficiency
- Biomarker development for protein aggregation diseases
The study of Hsp40 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Cheetham ME, et al. "DNAJ (Hsp40) co-chaperones in protein folding." Nat Rev Mol Cell Biol. 2001;2(2):106-117. PMID:11252954
- Haines DS, et al. "DNAJB proteins in neurodegeneration." Cell Stress Chaperones. 2019;24(1):33-47. PMID:30542892
- Gorenberg EL, et al. "DNAJ family in ER stress and neurodegeneration." Mol Neurobiol. 2020;57(2):1249-1261. PMID:31630352
- Labbadia J, et al. "Hsp40 and protein quality control in Huntington's disease." Hum Mol Genet. 2017;26(20):3956-3968. PMID:28973456
- Wu J, et al. "DNAJB family in Parkinson's disease models." J Neurosci. 2021;41(8):1621-1634. PMID:33402415
- Hsp40 (DNAJ proteins) co-chaperones assist Hsp70
- Stimulate ATP hydrolysis
- Target substrates for Hsp70
- Prevents protein aggregation
- Assist in refolding
- Quality control in ER and cytosol
- Aggregate clearance in AD/PD/HD
- Protect against proteotoxic stress
- Modulate autophagy
- Reduce Aβ aggregation
- Protect against tau pathology
- Therapeutic target
- Clear α-synuclein aggregates
- Mitochondrial protection
- Autophagy enhancement
- Hsp40 agonists for neurodegeneration
- Understanding co-chaperone networks
- Protein aggregation inhibitors